General Information of the Compound
| Compound ID |
CP0261934
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[1-(1,3-benzothiazol-6-ylsulfonyl)-5-chloroindol-2-yl]butanoic acid
Show/Hide
|
||||||||||||||||||
| Synonyms |
1-(6-Benzothiazolylsulfonyl)-5-chloro-1H-indole-2-butanoic Acid
1H-Indole-2-butanoic acid, 1-(6-benzothiazolylsulfonyl)-5-chloro-
28Q8AG0PYL
4-(1-(1,3-Benzothiazol-6-ylsulfonyl)-5-chloro-indol-2-yl)butanoic acid
4-(1-(benzo[d]thiazol-6-ylsulfonyl)-5-chloro-1H-indol-2-yl)butanoic acid
4-[1-(1,3-benzothiazol-6-ylsulfonyl)-5-chloro-indol-2-yl]butanoic acid
4-[1-(1,3-benzothiazol-6-ylsulfonyl)-5-chloroindol-2-yl]butanoic acid
5-Chloro-1-((6-benzothiazolyl)sulfonyl)-1H-indole-2-butanoic acid
927961-18-0
AC-31451
AK689102
AMY16813
BDBM50244350
BJB
BS-17993
CHEMBL4091374
CPD1537
CS-0027586
DB14801
EX-A1511
HY-104049
IVA-337
IVA337
Lanifbranor
Lanifbranor [INN]
Lanifibranor
Lanifibranor(IVA-337)
Libfranor
Q27896056
SB18746
SCHEMBL3528615
UNII-28Q8AG0PYL
s8770
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C19H15ClN2O4S2
|
||||||||||||||||||
| Molecular Weight |
434.926
|
||||||||||||||||||
| Canonical SMILES |
OC(=O)CCCc1cc2cc(Cl)ccc2n1S(=O)(=O)c1ccc2ncsc2c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C19H15ClN2O4S2/c20-13-4-7-17-12(8-13)9-14(2-1-3-19(23)24)22(17)28(25,26)15-5-6-16-18(10-15)27-11-21-16/h4-11H,1-3H2,(H,23,24)
Show/Hide
|
||||||||||||||||||
| InChIKey |
OQDQIFQRNZIEEJ-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
927961-18-0
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01919, Peroxisome proliferator-activated receptor alpha
Protein ID: PT00910, Peroxisome proliferator-activated receptor alpha
Protein ID: PT00909, Peroxisome proliferator-activated receptor delta
Protein ID: PT03063, Peroxisome proliferator-activated receptor delta
Protein ID: PT02973, Peroxisome proliferator-activated receptor gamma
Protein ID: PT00915, Peroxisome proliferator-activated receptor gamma
Clinical Information about the Compound